Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results

Lucid Diagnostics Inc (LUCD) PT Lowered to $2 at Cantor Fitzgerald

November 15, 2024 6:41 AM EST

Cantor Fitzgerald analyst Ross Osborn lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $2.00 (from $3.00) while maintaining a Overweight rating.

The analyst comments "We are lowering our price target to $2 from $3 as the company is still working through the process of receiving... More